U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07464132) titled 'Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases' on March 03.
Brief Summary: The purpose of this study is to conduct clinical research on [68Ga] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.
Study Start Date: Dec. 17, 2025
Study Type: INTERVENTIONAL
Condition:
Tumor
Cardiovascular Diseases
Pulmonary Fibrosis
Rheumatic Immune Diseases Involving Large Blood Vessels
Hypertrophic Cardiomyopathy (HCM)
Other Hypoxic and Fibroblast Activated Diseases
Intervention:
DRUG: Injection of 68Ga-NI-FAPI
Subjects were i...